MoneyWorks4Me

Themis Medicare informs about analyst meet

17 Feb 2023 Evaluate

Pursuant to regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘the Listing Regulations’) read with part A of Schedule III of the Listing Regulations, Themis Medicare has informed that the management of the Company did a one-on-one physical meeting with Analysts/Investors ‘Nuvama Wealth Management’ on Thursday, 16th February 2023 at the company's Office. Pursuant to regulation 46(2) of the Listing Regulations, aforesaid information shall be disclosed on the website of the company: www.themismedicare.com.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..